亚斯丁通过ERK1/2信号通路缓解慢性前列腺炎:来自网络药理学和实验验证的证据
Yifu Liu1,2, Liang Huang3, Zhicheng Zhang1,2
1Department of Urology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, China.
Combinatorial chemistry & high throughput screening
|October 16, 2024
概括
阿斯丁 (AST) 通过减少炎症和向ERK1/2通路,显示出治疗慢性前列腺炎 (CP) 的潜力. 需要进一步的临床试验来确认它在患者中的有效性.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 阿斯塔丁 (AST) 以其抗炎性质而闻名.
- 慢性前列腺炎 (CP) 是一种炎症性疾病,需要有效的治疗.
研究的目的:
- 在慢性前列腺炎的小鼠模型中研究AST的治疗疗效.
- 阐明AST在CP的抗炎作用的潜在分子机制.
主要方法:
- 通过使用完整的弗洛恩德辅助剂 (CFA) 建立了一种小鼠CP模型.
- 评估了AST对前列腺炎症和促炎细胞因子 (IL-6,IL-8) 的影响.
- 网络药理学和西方抹杀被用来识别AST的分子标,重点关注ERK1/2通路.
主要成果:
- 在CP大鼠中,AST的使用减少了前列腺结构的变化和炎症细胞的透.
- AST抑制了前列腺细胞中的IL-6和IL-8表达,并抑制了ERK1/2酸化.
- AST和ERK1/2通路抑制剂显示出协同作用的抗炎作用.
结论:
- 亚斯丁通过调节炎症通路,显示出慢性前列腺炎的治疗潜力.
- 在CP中AST的抗炎作用与ERK1/2通路的调节有关.
- 建议通过随机对照试验进行临床验证,以确认AST在CP患者的疗效.
相关概念视频
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
137
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
137


